PHOENIX BIOTECHNOLOGY INC

Profile

Company Names

PHOENIX BIOTECHNOLOGY INC

Addresses

8626 TESORO DR, SUITE 801, SAN ANTONIO, TX 78217

Phone Numbers

210-828-4373

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

TEXAS

Total Amount Raised:

$10,913,364.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-08-07 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
3
2018-07-18 
$1,760,700.00 
INDEFINITE 
INDEFINITE 
Equity 
2
2014-03-19 
$852,000.00 
$2,000,000.00 
$1,148,000.00 
Equity 
1
2010-08-17 
$3,300,664.00 
$3,600,000.00 
$299,336.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CRANDELL 
 
ADDINGTON 
EXECUTIVE OFFICER, DIRECTOR
ANDREW 
J. 
BUTLER 
DIRECTOR
JOHN 
W. 
CREAMER 
DIRECTOR
MACDONALD 
T. 
HASKELL 
DIRECTOR
LOU 
 
KOST 
EXECUTIVE OFFICER, DIRECTOR
LOU 
 
KOST, JR. 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
NEWMAN 
DIRECTOR, EXECUTIVE OFFICER
ROBERT 
A. 
NEWMAN 
EXECUTIVE OFFICER, DIRECTOR
JEFFREY 
S. 
THOMPSON 
DIRECTOR
CARLOS 
 
TORRES 
EXECUTIVE OFFICER
ANDREW 
 
WHITNEY 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-07 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-18 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-18 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-19 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-17 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-08-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#